Cadre (NYSE:CDRE) and Conformis (NASDAQ:CFMS) are both small-cap industrial products companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.
This is a summary of recent ratings for Cadre and Conformis, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Earnings & Valuation
This table compares Cadre and Conformis’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Conformis||$68.76 million||1.81||-$24.29 million||($0.03)||-22.26|
Cadre has higher earnings, but lower revenue than Conformis.
Institutional and Insider Ownership
39.2% of Conformis shares are owned by institutional investors. 3.0% of Conformis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This table compares Cadre and Conformis’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Conformis beats Cadre on 8 of the 9 factors compared between the two stocks.
Cadre Holdings Inc. is a manufacturer and distributer of safety and survivability equipment for first responders. The Company’s core products include body armor, explosive ordnance disposal equipment and duty gear. Its primarily brands include Safariland(R) and Med-Eng(R). Cadre Holdings Inc. is headquartered in Jacksonville, Florida.
ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States; Germany; and Rest of the World. The firm’s products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.